2,104
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Integrating DOI in T classification improves the predictive performance of laryngeal cancer staging

, , , , , , , , , , & ORCID Icon show all
Article: 2169040 | Received 08 Apr 2022, Accepted 14 Sep 2022, Published online: 02 Feb 2023

References

  • Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP. Head and Neck cancers-major changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122–9. 10.3322/caac.21389.
  • Yunker WK, Matthews TW, Dort JC. Making the most of your pathology: standardized histopathology reporting in head and neck cancer. J Otolaryngol Head Neck Surg. 2008;37(1):48–55.none.
  • King B, Corry J. Pathology reporting in head and neck cancer–snapshot of current status. Head Neck. 2009;31(2):227–231. doi:10.1002/hed.20957. discussion 32-3.
  • International Consortium for Outcome Research H NC, Ebrahimi A, Gil Z, Amit M, Yen TC, Liao CT, Chaturvedi P, Agarwal JP, Kowalski LP, Cernea CR, et al. Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: an international multicenter retrospective study. JAMA Otolaryngol Head Neck Surg. 2014;140(12):1138–1148. 10.1001/jamaoto.2014.1548
  • Liao CT, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Hsieh CH, Ng SH, Lin CH, Tsao CK, et al. Tumor depth of invasion (Tumor > 4 cm/Depth > 10 mm and Depth > 20 mm) and through cortex/skin invasion are both valid criteria for classifying tumors as pT4a in AJCC 2018 oral cavity cancer staging system. Ann Surg Oncol. 2019;26(11):3663–3672. DOI:10.1245/s10434-019-07576-5
  • Tam S, Amit M, Zafereo M, Bell D, Weber RS. Depth of invasion as a predictor of nodal disease and survival in patients with oral tongue squamous cell carcinoma. Head Neck. 2019;41(1):177–184. 10.1002/hed.25506.
  • Peters LJ, Goepfert H, Ang KK, Byers RM, Maor MH, Guillamondegui O, Morrison WH, Weber RS, Garden AS, Frankenthaler RA, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys. 1993;26(1):3–11. DOI:10.1016/0360-3016(93)90167-t
  • Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350(19):1945–1952. DOI:10.1056/NEJMoa032641
  • Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350(19):1937–1944. DOI:10.1056/NEJMoa032646
  • Lau L, Eu D, Loh T, Ahmed Q, Lim CM. Histopathologic prognostic indices in tongue squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2020;278(7):2461–2471. 10.1007/s00405-020-06329-5.
  • Park JY, Kim SY, Shin DH, Choi KU, Kim JY, Sol MY, Lee HJ, Hwang C, Ryu JH, Yang KH, et al. Validation of the T category for distal cholangiocarcinoma: measuring the depth of invasion is complex but correlates with survival. Ann Diagn Pathol. 2020;46:151489. 10.1016/j.anndiagpath.2020.151489.
  • Tomar AS, Finger PT, Gallie B, Mallipatna A, Kivela TT, Zhang C, Zhao J, Wilson MW, Kim J, Khetan V, et al. A multicenter, international collaborative study for American joint committee on cancer staging of retinoblastoma: part i: metastasis-associated mortality. Ophthalmology. 2020;127(12):1733–1746. DOI:10.1016/j.ophtha.2020.05.050
  • Isom C, Wheless L, Hooks MA, Kauffmann RM. Early melanoma nodal positivity and biopsy rates before and after implementation of the 7th edition of the AJCC cancer staging manual. JAMA Dermatol. 2019;155(5):572–577. 10.1001/jamadermatol.2018.5902.
  • Yilmaz T, Hosal S, Gedikoglu G, Turan E, Ayas K. Prognostic significance of depth of invasion in cancer of the larynx. Laryngoscope. 1998;108(5):764–768. 10.1097/00005537-199805000-00025.
  • Ye LL, Rao J, Fan XW, Kong FF, Hu CS, Ying HM. The prognostic value of tumor depth for cervical lymph node metastasis in hypopharyngeal and supraglottic carcinomas. Head Neck. 2019;41(7):2116–2122. 10.1002/hed.25667.
  • Tomifuji M, Imanishi Y, Araki K, Yamashita T, Yamamoto S, Kameyama K, Shiotani A. Tumor depth as a predictor of lymph node metastasis of supraglottic and hypopharyngeal cancers. Ann Surg Oncol. 2011;18(2):490–496. 10.1245/s10434-010-1219-5.
  • Harrell FE Jr., Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247(18):2543–6.none. doi:10.1001/jama.1982.03320430047030.
  • Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–7259. 10.1158/1078-0432.CCR-04-0713.
  • Friedland PL, Bozic B, Dewar J, Kuan R, Meyer C, Phillips M. Impact of multidisciplinary team management in head and neck cancer patients. Br J Cancer. 2011;104(8):1246–1248. 10.1038/bjc.2011.92.
  • Dirven R, Ebrahimi A, Moeckelmann N, Palme CE, Gupta R, Clark J. Tumor thickness versus depth of invasion - Analysis of the 8th edition American joint committee on cancer staging for oral cancer. Oral Oncol. 2017;74:30–33. 10.1016/j.oraloncology.2017.09.007.
  • Howaldt HP, Kainz M, Euler B, Vorast H. Proposal for modification of the TNM staging classification for cancer of the oral cavity. DOSAK J Craniomaxillofac Surg. 1999;27(5):275–288. 10.1054/jcms.1999.0070.
  • Yuen AP, Lam KY, Wei WI, Lam KY, Ho CM, Chow TL, Yuen WF. A comparison of the prognostic significance of tumor diameter, length, width, thickness, area, volume, and clinicopathological features of oral tongue carcinoma. Am J Surg. 2000;180(2):139–143. 10.1016/s0002-9610(00)00433-5.
  • Greenlee H, Unger JM, LeBlanc M, Ramsey S, Hershman DL. Association between body mass index and cancer survival in a pooled analysis of 22 clinical trials. Cancer Epidemiol Biomarkers Prev. 2017;26(1):21–29. 10.1158/1055-9965.EPI-15-1336.
  • Strulov Shachar S, Williams GR. The obesity paradox in cancer-moving beyond BMI. Cancer Epidemiol Biomarkers Prev. 2017;26(1):13–16. 10.1158/1055-9965.EPI-16-0439.